knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 17:30:03 - browse：15446

Blood samples — Marion Berard/AFP/GettyImages

With the advent of disease-modifying Alzheimer’s drugs, everyone in the world of Alzheimer’s diagnostics is bracing for the crush.

Based on their ability to slow cognitive decline, the Eisai/Biogen drug Leqembi won full approval from the FDA this month, and donanemab by Eli Lilly could be approved by year end. Clinicians now have to decide which patients are most suitable for treatment, which means better Alzheimer’s tests need to be developed.

“There’s going to be capacity issues because there’s just not enough neurologists in the world to treat this pool of patients with Alzheimer’s disease at the moment,” said Mark Stearman, a senior international product manager at Roche focusing on Alzheimer’s diagnostics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

WSS

Covid’s new normal has set in amid another rise in cases

Fentanyl is making it harder to start addiction treatment

FDA poised to publish guidelines for clinical trial diversity

How the messy conversation about Dolly changed bioethics

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

David Liu startup to focus on CRISPR delivery

Wikipedia

knowledge

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Fentanyl is making it harder to start addiction treatment

23andMe had bad news about my health. I wish a person had delivered it

Scrutiny of post

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Free Covid tests will again be offered to all U.S. households

Malaria cases in Florida and Texas: Here’s what you need to know

David Liu startup to focus on CRISPR delivery

How one medical school became remarkably diverse

Scrutiny of post

focus

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Neurocrine congenital adrenal hyperplasia trial succeeds

'A game

UnitedHealth argues against case alleging wrongful AI care denials

Chamber of Commerce, DOJ clash in court over drug prices

FDA weighs limits of animal data in assessing artificial wombs

Wikipedia

entertainment

hotspot

knowledge